Both in Pharmaceuticals
Amphastar Pharmaceuticals vs Nektar Therapeutics
Over the past year AMPH returned +10.9% and NKTR returned −31.3%; their daily moves had a correlation of 0.05.
AMPH +10.9% NKTR −31.3%Growth of $1, one year, split-adjusted
| Metric | AMPH | NKTR |
|---|---|---|
| Price | $28.02 | $38.48 |
| Market cap | $1.19B | $1.31B |
| Today | +3.32% | +1.91% |
| 1 month | +8.1% | −3.6% |
| 6 months | +17.2% | −54.8% |
| Year to date | +4.6% | −9.0% |
| 1 year | +10.8% | −35.8% |
| Revenue growth (YoY) | +5.4% | −9.3% |
| Gross margin | 50.8% | 100.0% |
| Net margin | 16.5% | −401.0% |
| P/E (TTM) | 15.2× | — |
| Price / sales | 1.6× | 24.1× |
| Net cash | -$321.9M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | 31.3% | 70.0% |
| Short % of float | 14.9% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).